NorthWest Biotherapeutics Inc (NWBO)

[CrashOverride]

Researchers are now aware of pseudoprogression so should be able to control for that false positive. I believe with secondary endpoints which validate the tumors are dead we will see surrogates like PFS used in future trials so they won't take as long as they would with overall survival as the primary endpoint. BP can't fix this problem nor could they run the trial any better than NWBO's world-class management. In fact all of the GBM trials which BP ran were complete failures.